Liljedahl, L.; Malmström, J.; Kristjansdottir, B.; Waldemarson, S.; Sundfeldt, K.
Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian Cancer. Cancers 2021, 13, 5713.
https://doi.org/10.3390/cancers13225713
AMA Style
Liljedahl L, Malmström J, Kristjansdottir B, Waldemarson S, Sundfeldt K.
Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian Cancer. Cancers. 2021; 13(22):5713.
https://doi.org/10.3390/cancers13225713
Chicago/Turabian Style
Liljedahl, Leena, Johan Malmström, Björg Kristjansdottir, Sofia Waldemarson, and Karin Sundfeldt.
2021. "Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian Cancer" Cancers 13, no. 22: 5713.
https://doi.org/10.3390/cancers13225713
APA Style
Liljedahl, L., Malmström, J., Kristjansdottir, B., Waldemarson, S., & Sundfeldt, K.
(2021). Targeted Selected Reaction Monitoring Verifies Histology Specific Peptide Signatures in Epithelial Ovarian Cancer. Cancers, 13(22), 5713.
https://doi.org/10.3390/cancers13225713